# Wugen

**Canonical:** https://apis.io/providers/wugen/  
**Website:** https://alloteratx.com/  
**APIs profiled:** 7

Wugen, Inc. is a St. Louis, Missouri clinical-stage cell-therapy company founded in 2018 out of Washington University in St. Louis that develops off-the-shelf, allogeneic CAR-T and memory NK cell therapies for blood cancers, using CRISPR deletion of the T-cell receptor so cells from healthy donors can be given without graft-versus-host disease. In July 2026 the company renamed itself Allotera Therapeutics, Inc. and moved to alloteratx.com, closing a $35M financing that brought total capital raised to roughly $150M on top of its $115M Series C; its lead program, soficabtagene geleucel (sofi-cel, formerly WU-CART-007), is a CD7-targeted allogeneic CAR-T in a global pivotal study for relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, holds FDA Breakthrough Therapy designation, and was selected for the FDA CMC Development and Readiness Pilot Program. Wugen/Allotera publishes no product or developer API, no OpenAPI, no llms.txt and no agent card. The only machine-readable surface either domain exposes is the WordPress REST API (wp/v2), anonymously readable on both the current alloteratx.com site and the retired wugen.com brand domain, which still serves the complete historical press-release and scientific-publication archive as JSON even though its human-facing site is now a single splash page.

## Kin Score — 27.2 / 100 (emerging)

Scored 2026-08-12 under rubric 0.11.0. Trend: flat (+0.0 from 27.2).

| Facet | Score |
|---|---|
| Discoverability | 92.6 |
| Contract Quality | 45.0 |
| Governance | 11.5 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 16.8 |
| Commercial Clarity | 10.5 |

Regulatory layer — **Health**: 26.3 (matched via tags).

## Agent readiness — 37.4 (agent-ready)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | derived |
| MCP Server | no |
| Auth Clarity | yes |
| Idempotency | no |
| Error Semantics | documented |
| OpenAPI Examples | documented |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | derived |
| Well Known Catalog | yes |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## APIs (7)

- **Wugen Comments API** — The Comments API from Wugen — 2 operation(s) for comments.
- **Wugen Discovery API** — The Discovery API from Wugen — 7 operation(s) for discovery.
- **Wugen Media API** — The Media API from Wugen — 2 operation(s) for media.
- **Wugen Pages API** — The Pages API from Wugen — 2 operation(s) for pages.
- **Wugen Posts API** — The Posts API from Wugen — 2 operation(s) for posts.
- **Wugen Search API** — The Search API from Wugen — 1 operation(s) for search.
- **Wugen Taxonomy API** — The Taxonomy API from Wugen — 4 operation(s) for taxonomy.

## Agentic access (1)

- **Wugen Agentic Access** — 38 operations

## Security (2)

- **Wugen Authentication** — 0 schemes
- **Wugen Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Cell Therapy, Oncology, Life Sciences, Pharmaceuticals, Clinical Trials, CAR-T, CRISPR, Immunotherapy, Research, Content

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/wugen/). Scores are computed from the provider's own public artifacts under a published rubric.